文献速递母胎医学产科

潘多拉妊娠:无创产前检测、染色体微阵列分析与基因组测序——产前基因检测新时代

Pandora's pregnancy: NIPT, CMA, and genome sequencing-A new era for prenatal genetic testing.
PubMed 文献 · Prenat Diagn · 2019-06-25

本文通过概念分析梳理产前诊断从传统核型分析向无创产前检测、染色体微阵列分析和全外显子组测序等先进基因技术的转变,这些技术检出率更高但带来大量不确定数据。作者基于近30年塑造父母与专业人员产前诊断社会伦理体验的奠基性研究,讨论概率与不确定性对知情同意、风险沟通、客户满意度和亲子依恋的影响。

要点

  • 产前诊断已从传统核型分析转向无创产前检测、染色体微阵列分析和全外显子组测序等先进基因技术。
  • 先进基因技术检出率更高,但产生大量不确定数据。
  • 概率与不确定性影响知情同意、风险沟通、决策和亲子依恋,咨询需应对不确定性与概率。

核心结论

  • 这些变化使产前诊断超越试探性妊娠与道德开拓的旧范式,进入不确定性、基于概率的咨询和道德/转化赌博的新阶段。
  • 作者最后讨论了在潘多拉妊娠时代维持希望所需的条件。

研究设计与样本

  • 概念分析,基于近30年塑造父母与专业人员产前诊断社会伦理体验的奠基性研究。

主要发现

  • 产前诊断从传统核型分析转向无创产前检测、染色体微阵列分析和全外显子组测序,检出率更高且不确定数据大量增加。
  • 既往研究记录了概率与不确定性如何影响知情同意/选择、健康风险沟通、客户满意度和决策以及亲子依恋。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We delineate in this article a shift from the "traditional" technologies of karyotyping in PND to the current phase of advanced genetic technologies including noninvasive prenatal testing (NIPT), chromosomal microarray analysis (CMA), and whole-exome sequencing (WES) with their higher detection rate and related abundance of uncertain data. METHODS: Conceptual analysis based on seminal works that shaped the socioethical discourse surrounding the experiences of parents as well as professionals with prenatal diagnosis in the last 30 years. RESULTS: We consider the implications of this new era of PND for patients and health professionals by drawing on previous studies documenting how probability and uncertainty affect informed consent/choice, health risks communication, customer satisfaction and decision making, and parent-child bonding. CONCLUSIONS: We argue that these changes move us beyond the idioms and realities of the tentative pregnancy and moral pioneering, to uncertainty, probability-based counseling, and moral/translational gambling. We conclude by discussing what is needed to maintain hope in the era of Pandora's pregnancy.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Hashiloni-Dolev Y, Nov-Klaiman T, Raz A, et al. Pandora's pregnancy: NIPT, CMA, and genome sequencing-A new era for prenatal genetic testing. Prenat Diagn. 2019. PMID: 31161621. doi:10.1002/pd.5495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。